The operating environment for medical technology companies becomes more complex, competitive and costly every year. There is no expectation that 2022 will buck that trend, even as the medtech sector prepares for a third year of working under conditions shaped by the COVID-19 pandemic.
In Vivo has collected the top 10 themes and talking points that will influence medtech decision-making and operating conditions in 2022.
Although there were some positional changes among the ranking of the leading 20 medtechs by sales in COVID-affected 2020, the...